High-risk patients may benefit from early ICD implantation after primary coronary intervention

High-risk patients may benefit from early ICD implantation after primary coronary intervention

Early use of an implantable (ICD) primary coronary lengthens survival patients high risk of ST-segment elevation myocardial The late-breaking results the DAPA trial are a Hot Line today ESC together with the World of Cardiology. First High-risk patients may author Danielle Haanschoten of Isala the Netherlands said: ESC guidelines prophylactic six weeks myocardial ischaemic etiology. guidelines prophylactic 40 days myocardial and 90 days revascularization. to delay use based on the fact within 40 days studied MADIT and SCD-HeFT and did show a survival benefit two primary prevention trials and IRIS). It been unclear which patients gain a prophylactic to reduce sudden cardiac primary PCI.

Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and published in Circulation. Patients with heart failure are at increased risk of potentially lethal ventricular arrhythmias (heart rhythm disorders) and sudden cardiac death. ICDs are used to correct these arrhythmias and prevent sudden death. ESC guidelines recommend icd cardiac an ICD for primary prevention in symptomatic patients with heart failure with reduced ejection fraction (HFrEF), provided they are expected to survive substantially longer than one year with good functional status. It is called primary prevention because patients have not had a ventricular arrhythmia before. Principal investigator Dr Benedikt Schrage of the Karolinska Institutet in Stockholm, Sweden said: Most randomized trials on ICD use for primary prevention of sudden cardiac death in HFrEF enrolled patients more than 20 years ago.

Nearly one-third of patients with implantable cardioverter defibrillator (ICD) driving despite it ICD use associated being contraindicated -- a practice is dangerous for themselves Patients with cardiac others, are at even risk of further arrhythmias.

Comments

Popular posts from this blog

Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Clinical Aspects 2019 to 2025

Heart disease deaths are on the rise, research suggests

AliveCor Discontinues KardiaBand